Risk factors for interstitial lung disease: A 9-year Nationwide population-based study

Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis

9 p | 7 | 2

Fatal interstitial lung disease associated with Crizotinib pathologically confirmed by percutaneous lung biopsy in a patient with ROS1-rearranged advanced non-small-cell lung cancer: A case report

6 p | 18 | 1

Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia

7 p | 11 | 0